cube-tech.ru


PCRX STOCK FORECAST

PCRX - Pacira Pharmaceuticals - Stock Forecast PCRX is currently covered by 11 analysts with an average price target of $ This is a potential upside of. Pacira BioSciences Stock Forecast, PCRX stock price prediction. Price target in 14 days: USD. The best long-term & short-term Pacira BioSciences. Pacira Pharmaceuticals (PCRX) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The 10 analysts with month price forecasts for Pacira BioSciences stock have an average target of , with a low estimate of 38 and a high estimate of Pacira BioSciences (PCRX) stock price prediction is USD. The Pacira BioSciences stock forecast is USD for June

Based on the Pacira Pharmaceuticals Inc stock forecast from 7 analysts, the average analyst target price for Pacira Pharmaceuticals Inc is USD over the. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCRX is experiencing. PCRX | Complete Pacira BioSciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Pacira BioSciences (NASDAQ:PCRX) Stock, Analyst Ratings, Price Targets, Predictions Pacira BioSciences Inc has a consensus price target of $, established. Pacira BioSciences Stock Forecast ; Buy ratings: 3, 3 ; Hold ratings: 0, 0 ; Sell ratings: 0, 0 ; Strong sell ratings: 0, 0. Pacira Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold. The current price of PCRX is USD — it has decreased by % in the past 24 hours. Watch Pacira BioSciences, Inc. stock price performance more closely on. The intrinsic value of one PCRX stock under the Base Case scenario is USD. Compared to the current market price of USD, Pacira Biosciences Inc is. Jefferies Maintains Pacira BioSciences(cube-tech.ru) With Buy Rating, Maintains Target Price $36 · Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of. Pacira BioSciences Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Based on short-term price targets offered by 10 analysts, the average price target for Pacira comes to $ The forecasts range from a low of $ to a.

Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel The small drugmaker posted record sales for its flagship drug in the first quarter. Find the latest Pacira BioSciences, Inc. (PCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. According to analysts, Pacira BioSciences's stock has a predicted upside of % based on their month stock forecasts. Get a real-time Pacira BioSciences, Inc. (PCRX) stock price quote with breaking news, financials, statistics, charts and more. Discover real-time Pacira BioSciences, Inc. Common Stock (PCRX) stock prices, quotes, historical data, news, and Insights for informed trading and. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Pacira Pharmaceuticals to be priced at by the end of this quarter and. On average, analysts forecast that PCRX's EPS will be $ for , with the lowest EPS forecast at $, and the highest EPS forecast at $ In Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Became profitable this year · Analysts in good agreement. Get Pacira Biosciences Inc (PCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Based on 10 analysts giving stock ratings to PCRX in the past 3 months. Neutral. SellBuy. Strong sell. View Pacira Biosciences, Inc. PCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Get updated information on Pacira BioSciences, Inc. Common Stock (PCRX) Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluations with Nasdaq. Pacira BioSciences (NASDAQ:PCRX) Stock, Analyst Ratings, Price Targets, Predictions Pacira BioSciences Inc has a consensus price target of $, established. Earnings for Pacira BioSciences are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the Market. The P/.

Pacira (PCRX) has an AI Score of 6/10 (Hold) because its overall probability of beating the market (S&P ) in the next 3 months (%) is +% vs. the. Pacira Pharmaceuticals PCRX share price targets for May month are on upside & on downside ; Upside Price target, ; Upside Price target, Get Pacira Biosciences Inc (cube-tech.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. For the Pacira BioSciences Inc forecast (traded under symbol PCRX) for one year forward price target at the top of this page, we have presented the average PCRX. What is the forecast for Pacira BioSciences (PCRX) stock? A. Pacira BioSciences has a consensus price target of $ Q. Current.

flap bird | stock news today live

44 45 46 47 48


Copyright 2012-2024 Privice Policy Contacts SiteMap RSS